MENU
+Compare
RXST
Stock ticker: NASDAQ
AS OF
Jun 13, 04:59 PM (EDT)
Price
$14.22
Change
-$0.05 (-0.35%)
Capitalization
1.91B

RXST RxSight Forecast, Technical & Fundamental Analysis

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery... Show more

RXST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RXST with price predictions
Jun 12, 2025

RXST's Stochastic Oscillator slumps into oversold zone

The Stochastic Oscillator for RXST moved into oversold territory on June 12, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for RXST crossed bullishly above the 50-day moving average on June 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RXST advanced for three days, in of 228 cases, the price rose further within the following month. The odds of a continued upward trend are .

RXST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RXST as a result. In of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RXST turned negative on June 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

RXST moved below its 50-day moving average on June 11, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RXST entered a downward trend on May 15, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.641) is normal, around the industry mean (24.242). P/E Ratio (15.267) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (19.531) is also within normal values, averaging (42.497).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RXST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RXST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
RXST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RXST is expected to report earnings to rise 466.00% to -16 cents per share on August 11

RxSight RXST Stock Earnings Reports
Q2'25
Est.
$-0.17
Q1'25
Beat
by $0.17
Q4'24
Beat
by $0.20
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.06
The last earnings report on May 07 showed earnings per share of -2 cents, beating the estimate of -20 cents. With 189.32K shares outstanding, the current market capitalization sits at 1.91B.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
100 Columbia
Phone
+1 949 521-7830
Employees
374
Web
https://www.rxsight.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVSIX14.880.03
+0.20%
Janus Henderson Small-Mid Cap Value I
JUEAX25.04N/A
N/A
JPMorgan US Equity A
COSOX12.00N/A
N/A
Columbia Overseas Core Institutional 3
CMIEX13.42N/A
N/A
Multi-Manager Intl Eq Strats Instl
TCFSCV10.16N/A
N/A
Thrivent Core Small Cap Value

RXST and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RXST has been loosely correlated with GKOS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if RXST jumps, then GKOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXST
1D Price
Change %
RXST100%
-4.29%
GKOS - RXST
40%
Loosely correlated
-1.56%
ESTA - RXST
40%
Loosely correlated
-3.68%
SONVY - RXST
36%
Loosely correlated
+1.15%
TRUMY - RXST
34%
Loosely correlated
+0.99%
MASI - RXST
34%
Loosely correlated
-1.00%
More